Study of methods for the detection of HBsAg and HBsAb in hemoderivatives. 1977

A Costantini, and D Jori, and P Lorenzini, and O Lostia

For application to the control of hemoderivatives of the methods adopted for the detection of HBsAg and HBsAb in sera or plasma, using radioimmunological kits, it is necessary for the methods to have greater sensitivity and reliability, which can be achieved by employing complementary tests or by modifying certain phases of the normal methods. Particularly in the case of hemoderivatives with a high infectivity risk, application of the normal procedures entails problems of a kind such as to rule out the test altogether or to adversely affect its reliability. The preliminary data obtained with modifications of the methods according to the Abbott AUSRIA II and AUSAB RIA kits are here reported; these data seem to indicate that the reliability of the tests is improved.

UI MeSH Term Description Entries
D007106 Immune Sera Serum that contains antibodies. It is obtained from an animal that has been immunized either by ANTIGEN injection or infection with microorganisms containing the antigen. Antisera,Immune Serums,Sera, Immune,Serums, Immune
D010949 Plasma The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION. Blood Plasma,Fresh Frozen Plasma,Blood Plasmas,Fresh Frozen Plasmas,Frozen Plasma, Fresh,Frozen Plasmas, Fresh,Plasma, Blood,Plasma, Fresh Frozen,Plasmas,Plasmas, Blood,Plasmas, Fresh Frozen
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D001793 Blood Preservation The process by which blood or its components are kept viable outside of the organism from which they are derived (i.e., kept from decay by means of a chemical agent, cooling, or a fluid substitute that mimics the natural state within the organism). Blood Preservations,Preservation, Blood,Preservations, Blood
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia

Related Publications

A Costantini, and D Jori, and P Lorenzini, and O Lostia
June 1976, Acta hepato-gastroenterologica,
A Costantini, and D Jori, and P Lorenzini, and O Lostia
January 1978, Srpski arhiv za celokupno lekarstvo,
A Costantini, and D Jori, and P Lorenzini, and O Lostia
January 1975, Bollettino dell'Istituto sieroterapico milanese,
A Costantini, and D Jori, and P Lorenzini, and O Lostia
March 2013, Journal of hepatology,
A Costantini, and D Jori, and P Lorenzini, and O Lostia
January 1979, Archivio per le scienze mediche,
A Costantini, and D Jori, and P Lorenzini, and O Lostia
April 1978, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
A Costantini, and D Jori, and P Lorenzini, and O Lostia
November 2018, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition,
A Costantini, and D Jori, and P Lorenzini, and O Lostia
September 1980, Casopis lekaru ceskych,
A Costantini, and D Jori, and P Lorenzini, and O Lostia
January 2017, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition,
A Costantini, and D Jori, and P Lorenzini, and O Lostia
January 2016, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi,
Copied contents to your clipboard!